India's Breakthrough: The Launch of Nafithromycin to Combat Antimicrobial Resistance India has taken a significant stride in the global fight against antimicrobial resistance (AMR) with the launch of its first indigenous antibiotic, Nafithromycin. Developed in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC) and marketed by Wockhardt under the brand name Miknaf, Nafithromycin represents a major breakthrough in the battle against drug-resistant bacteria. Understanding Antimicrobial Resistance Antimicrobial resistance (AMR) is a growing global health crisis where bacteria, viruses, fungi, and parasites have developed resistance to antimicrobial drugs, making infections harder to treat and increasing the risk of disease spread, severe illness, and death. 1 Causes of AMR: Overuse and misuse of antibiotics Lack of infection prevention and control measures Poor hygiene and sanitation Genetic mutations in microorganisms Impact of AMR: Increased ...